BP vs CHRD Stock Comparison
CHRD currently leads BP in this stock comparison, with AIQ scores of 61 vs 55. The clearest difference is quality, while BP has the stronger value profile.
What is the main difference between BP and CHRD?
CHRD leads the current stock comparison as Chord Energy Corporation, with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
BP p.l.c. vs Chord Energy Corporation
CHRD leads
CHRD leads by 6 AIQ points, primarily on Quality and Risk Resilience, having only recently taken the lead back from BP.
Fragile: 4 of 6 evidence groups support CHRD, the lead recently changed hands, and its signal state is cleanly positive.
BP p.l.c.
Chord Energy Corporation
The Algovestiq AIQ Score currently favors CHRD over BP, 61 versus 55 as of Oct 31, 2026. CHRD's advantage is driven primarily by stronger quality and risk resilience, while BP holds the stronger value profile. CHRD also shows the weaker technical structure relative to its 50-day moving average. 4 of 6 covered evidence groups favor CHRD today, and the comparison is rated Fragile on stability: the lead has already changed hands inside the comparison window. CHRD lead: Reversed — BP led by 2 AIQ points 30 sessions ago; CHRD now leads by 6.
Compare BP p.l.c. and Chord Energy Corporation across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare BP and CHRD against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality31 vs 50CHRD +19
- Risk Resilience43 vs 50CHRD +7
- Value69 vs 63BP +6
- Momentum75 vs 80CHRD +5
4 of 6 evidence groups favor CHRD. CHRD’s edge is concentrated in quality and risk resilience; BP keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Momentum -3
No signal started or stopped since the prior session; its 5 active signals are unchanged.
Largest factor move: Momentum -2
No signal started or stopped since the prior session; its 4 active signals are unchanged.
CHRD's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — BP and CHRD both carry a full feed there.
The central trade-off
CHRD (Chord Energy Corporation): the stronger current systematic profile, led by quality and risk resilience.
BP (BP p.l.c.): the counter-case, on value, valuation.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
CHRDCHRD on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
EvenGrowth figures are not covered for both names.
Value
BPBP on the peer-relative Value factor, by 6 points.
Momentum
CHRDCHRD on the Momentum factor, by 5 points.
Lower downside
CHRDCHRD on Risk Resilience, by 7 points.
Analyst upside
CHRDCHRD on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | BP | CHRD | Note |
|---|---|---|---|
| Implied upside to target | 0% | +11% | CHRD has more room |
| Target dispersion | +29.8% | +29.8% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 5 | 8 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
4 of 6 covered evidence groups favor CHRD. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | CHRD | 55 vs 61 |
| Fundamentals | CHRDon balance | revenue growth 34.2% vs 30.4%; TTM ROE 9.5% vs 10.4%; gross margin 21.9% vs 27.4%; operating margin 13.7% vs 18.9% — CHRD takes 3 of 4 decided legs, not all of them |
| Valuation | BP | Value 69 vs 63 |
| Technicals | Even | Price vs 50-day 10.2% vs 7.8%; vs 200-day 16.2% vs 17.9% |
| Risk Resilience | CHRD | Risk Resilience 43 vs 50 |
| Analyst expectations | CHRD | Target upside 0% vs 11% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BP and CHRD and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 6 points.
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on CHRD.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28CHRD lead: Reversed — BP led by 2 AIQ points 30 sessions ago; CHRD now leads by 6.
- Today
- CHRD +6
- 55 vs 61
- 7 sessions ago
- CHRD +5
- 57 vs 62
- 30 sessions ago
- BP +2
- 51 vs 49
- 90 sessions ago
- CHRD +7
- 52 vs 59
The lead changed hands 5 times in this window, most recently on Oct 12 when CHRD moved ahead of BP.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
5 bullish / 0 bearish
Only BP
- 52-Week High Proximity — bullish, risk, long horizon (2.0%)
4 bullish / 0 bearish
No signal that the other name lacks.
Both carry 4 more signals that do not separate them: Golden Cross Active, EMA Ribbon Expansion Bullish, Uptrend Structure Active, MACD Bullish Crossover.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +0.08%, AIQ -1 points).
Price is up while the AIQ Score moved down 1 points over the same session — price and model disagree (price +2.19%, AIQ -1 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1BP closes the Quality gap — currently 19 points behind, the largest single contributor to CHRD's edge.
- 2BP's existing bullish trend signals translate into factor-score gains — the rules are already firing, but the scores have not yet followed.
- 3CHRD's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
CHRD leads on balance| Metric | BP | CHRD |
|---|---|---|
| Revenue growth (YoY) | 34.2% | 30.4% |
| EPS growth (YoY) | 0% | 3.9% |
| Gross margin | 21.9% | 27.4% |
| Operating margin | 13.7% | 18.9% |
| Return on equity (TTM) | 9.5% | 10.4% |
| Debt to equity | 1.24 | 0.18 |
Performance
CHRD leads 4 of 6 windows| Metric | BP | CHRD |
|---|---|---|
| 1 week (5 sessions) | -0.1% | 2.1% |
| 1 month (20 sessions) | 13.2% | 14.9% |
| 3 months (63 sessions) | 12.6% | 11.4% |
| 6 months (126 sessions) | 6.4% | 5.4% |
| Year to date | 43.4% | 66.2% |
| 1 year (252 sessions) | 44.2% | 66.6% |
Technicals
Split| Metric | BP | CHRD |
|---|---|---|
| RSI (14) | 65.9 | 68.4 |
| ADX (14) | 33.1 | 17.2 |
| Price vs 50-day | 10.2% | 7.8% |
| Price vs 200-day | 16.2% | 17.9% |
| Volatility (1M, annualized) | 30.2% | 32.7% |
Risk
CHRD is the more resilient| Metric | BP | CHRD |
|---|---|---|
| Beta | -0.47 | -0.77 |
| Sharpe ratio | 1.25 | 1.45 |
| Sortino ratio | 1.8 | 2.22 |
| Max drawdown | -24.1% | -25.4% |
| Current drawdown | -3% | -2.6% |
| Annualized volatility | 30.1% | 39.5% |
| Value at risk (95%) | -3.3% | -3.8% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BP or CHRD?
On the Algovestiq AIQ Score, CHRD is the stronger of the two as of Oct 31, 2026, scoring 61 against BP's 55. The edge comes from quality and risk resilience. BP is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BP or CHRD the better buy right now?
CHRD carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Fragile — 4 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the lead has already changed hands inside the comparison window. Treat the lead as provisional.
Why does the AIQ Score favor CHRD over BP?
The composite weights Quality, Value, Momentum and Risk Resilience. CHRD leads Quality by 19 points; CHRD leads Risk Resilience by 7 points; BP leads Value by 6 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BP or CHRD?
Analyst price targets imply 0% upside for BP and +11% for CHRD, so the Street currently favors CHRD. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BP or CHRD?
BP is the better-valued of the two on the peer-relative Value factor. BP on the peer-relative Value factor, by 6 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BP or CHRD?
Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BP or CHRD?
CHRD on the Momentum factor, by 5 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BP or CHRD?
CHRD is the more resilient of the two, so the other name carries the higher downside risk. CHRD on Risk Resilience, by 7 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BP more profitable than CHRD?
CHRD leads on the comparable margin measures — gross margin 21.9% vs 27.4%; operating margin 13.7% vs 18.9%; ttm roe 9.5% vs 10.4%.
Is CHRD's lead over BP getting stronger or weaker?
CHRD lead: Reversed — BP led by 2 AIQ points 30 sessions ago; CHRD now leads by 6. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has changed hands 5 times in that window, most recently on 2026-10-12, when CHRD moved ahead of BP.
What would change the BP vs CHRD verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: BP closes the Quality gap — currently 19 points behind, the largest single contributor to CHRD's edge; BP's existing bullish trend signals translate into factor-score gains — the rules are already firing, but the scores have not yet followed; CHRD's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about BP and CHRD?
BP: 5 bullish / 0 bearish. CHRD: 4 bullish / 0 bearish. The most decision-relevant rule on BP is Golden Cross Active (bullish, long horizon). On CHRD it is Golden Cross Active (bullish, long horizon).
Compare BP and CHRD with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.